Author Interviews, Lancet, Parkinson's / 11.06.2014
Parkinson’s Disease: Are Newer Meds Better Than Levodopa?
MedicalResearch Interview with:
Richard Gray
Professor of Medical Statistics
Clinical Trial Service Unit
Richard Doll Building, Oxford
MedicalResearch: What are the main findings of the study?
Prof. Gray: We found that, when we asked patients with Parkinson’s disease how their drugs affected their overall quality of life, the older drug levodopa was better than newer, more expensive drugs and that this benefit persisted for at least seven years from starting treatment.
(more…)